MetLife Asia — Deferrals decreased by 4.2% to $114.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.5%, from $106.00M to $114.00M. Over 4 years (FY 2021 to FY 2025), Asia — Deferrals shows a downward trend with a -5.0% CAGR.
An increase reflects higher investment in business growth and acquisition, while a decrease may indicate reduced marketing spend or a shift in acquisition strategy.
This represents the capitalization of costs associated with acquiring or renewing insurance contracts in the Asia segmen...
Similar to Deferred Acquisition Costs (DAC) reported by most life and health insurance companies.
met_segment_asia_deferrals| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $152.50M | $152.50M | $152.50M | $158.00M | $145.00M | $114.00M | $129.00M | $105.00M | $178.00M | $194.00M | $190.00M | $152.00M | $133.00M | $139.00M | $110.00M | $106.00M | $123.00M | $148.00M | $119.00M | $114.00M |
| QoQ Change | — | +0.0% | +0.0% | +3.6% | -8.2% | -21.4% | +13.2% | -18.6% | +69.5% | +9.0% | -2.1% | -20.0% | -12.5% | +4.5% | -20.9% | -3.6% | +16.0% | +20.3% | -19.6% | -4.2% |
| YoY Change | — | — | — | — | -4.9% | -25.2% | -15.4% | -33.5% | +22.8% | +70.2% | +47.3% | +44.8% | -25.3% | -28.4% | -42.1% | -30.3% | -7.5% | +6.5% | +8.2% | +7.5% |